{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:49:05Z","timestamp":1794491345383,"version":"4.9.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["IRTG2290"],"award-info":[{"award-number":["IRTG2290"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Department of Education and Training | Australian Research Council","doi-asserted-by":"publisher","award":["DP180103212"],"award-info":[{"award-number":["DP180103212"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"DHAC | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1182369"],"award-info":[{"award-number":["APP1182369"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015211","name":"Department of Education, Skills and Employment, Australian Government","doi-asserted-by":"publisher","award":["Research Training Program Scholarship"],"award-info":[{"award-number":["Research Training Program Scholarship"]}],"id":[{"id":"10.13039\/501100015211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000995","name":"Australian National University","doi-asserted-by":"publisher","award":["IRTG2290"],"award-info":[{"award-number":["IRTG2290"]}],"id":[{"id":"10.13039\/501100000995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parasites, such as the malaria parasite\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    , are critically dependent on host nutrients. Interference with nutrient uptake can lead to parasite death and, therefore, serve as a successful treatment strategy.\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    parasites cannot synthesise cholesterol, and instead source this lipid from the host. Here, we tested whether cholesterol uptake pathways could be \u2018hijacked\u2019 for optimal drug delivery to the intracellular parasite. We found that fluorescent cholesterol analogues were delivered from the extracellular environment to the intracellular parasite. We investigated the uptake and inhibitory effects of conjugate compounds, where proven antimalarial drugs (primaquine and artesunate) were attached to steroids that mimic the structure of cholesterol. These conjugated antimalarial drugs improved the inhibitory effects against multiple parasite lifecycle stages, multiple parasite species, and drug-resistant parasites, whilst also lowering the toxicity to human host cells. Steroids with introduced peroxides also displayed antimalarial activity. These results provide a proof-of-concept that cholesterol mimics can be developed as a drug delivery system against apicomplexan parasites with the potential to improve drug efficacy, increase therapeutic index, and defeat drug resistance.\n                  <\/jats:p>","DOI":"10.1038\/s44321-024-00087-1","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:14:18Z","timestamp":1718090058000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Harnessing cholesterol uptake of malaria parasites for therapeutic applications"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9983-1474","authenticated-orcid":false,"given":"Merryn","family":"Fraser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-3938","authenticated-orcid":false,"given":"Blake","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-7030","authenticated-orcid":false,"given":"Kwong Sum","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Netzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2455-9821","authenticated-orcid":false,"given":"Giel G","family":"van Dooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-8162","authenticated-orcid":false,"given":"Alyssa","family":"Ingmundson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-8591","authenticated-orcid":false,"given":"Kai","family":"Matuschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-3226","authenticated-orcid":false,"given":"Malcolm D","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7369-1058","authenticated-orcid":false,"given":"Alexander G","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"87_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1128\/spectrum.00158-22","volume":"10","author":"AI Ahiya","year":"2022","unstructured":"Ahiya AI, Bhatnagar S, Morrisey JM, Beck JR, Vaidya AB, Vinayak S (2022) Dramatic consequences of reducing erythrocyte membrane cholesterol on Plasmodium falciparum. Microbiol Spectr 10:158\u2013180","journal-title":"Microbiol Spectr"},{"key":"87_CR2","doi-asserted-by":"publisher","first-page":"e1000406","DOI":"10.1371\/journal.pmed.1000406","volume":"8","author":"PL Alonso","year":"2011","unstructured":"Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM et al (2011) A research agenda to underpin malaria eradication. PLoS Med 8:e1000406","journal-title":"PLoS Med"},{"key":"87_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2013","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L et al (2013) A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505:50\u201355","journal-title":"Nature"},{"key":"87_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ (2014) Primaquine: the risks and the benefits. Malar J 13:418","journal-title":"Malar J"},{"key":"87_CR5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/424663","volume":"39","author":"JK Baird","year":"2004","unstructured":"Baird JK, Hoffman SL (2004) Primaquine therapy for malaria. Clin Infect Dis 39:1336\u20131345","journal-title":"Clin Infect Dis"},{"key":"87_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-511X-4-10","volume":"4","author":"D Bansal","year":"2005","unstructured":"Bansal D, Bhatti HS, Sehgal R (2005) Role of cholesterol in parasitic infections. Lipids Health Dis 4:10","journal-title":"Lipids Health Dis"},{"key":"87_CR7","doi-asserted-by":"publisher","first-page":"e19334","DOI":"10.1371\/journal.pone.0019334","volume":"6","author":"S Baumeister","year":"2011","unstructured":"Baumeister S, Wiesner J, Reichenberg A, Hintz M, Bietz S, Harb OS, Roos DS, Kordes M, Friesen J, Matuschewski K et al (2011) Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways. PLoS ONE 6:e19334","journal-title":"PLoS ONE"},{"key":"87_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini Y, Kreiger AM, Yekutieli D (2006) Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93:491\u2013507","journal-title":"Biometrika"},{"key":"87_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1021\/acsinfecdis.8b00277","volume":"5","author":"S Bhatnagar","year":"2019","unstructured":"Bhatnagar S, Nicklas S, Morrisey JM, Goldberg DE, Vaidya AB (2019) Diverse chemical compounds target Plasmodium falciparum plasma membrane lipid homeostasis. ACS Infect Dis 5:550\u2013558","journal-title":"ACS Infect Dis"},{"key":"87_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.pt.2022.01.011","volume":"38","author":"LM Birkholtz","year":"2022","unstructured":"Birkholtz LM, Alano P, Leroy D (2022) Transmission-blocking drugs for malaria elimination. Trends Parasitol 38:390\u2013403","journal-title":"Trends Parasitol"},{"key":"87_CR11","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1074\/jbc.M809420200","volume":"284","author":"I Bottova","year":"2009","unstructured":"Bottova I, Hehl AB, \u0160tefani\u0107 S, Fabri\u00e1s G, Casas J, Schraner E, Pieters J, Sonda S (2009) Host cell P-glycoprotein is essential for cholesterol uptake and replication of Toxoplasma gondii. J Biol Chem 284:17438\u201317448","journal-title":"J Biol Chem"},{"key":"87_CR12","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1128\/AAC.02541-14","volume":"58","author":"FF Boyom","year":"2014","unstructured":"Boyom FF, Fokou PVT, Tchokouaha LRY, Spangenberg T, Mfopa AN, Kouipou RMT, Mbouna CJ, Donfack VFD, Zollo PHA (2014) Repurposing the open access Malaria Box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica. Antimicrob Agents Chemother 58:5848","journal-title":"Antimicrob Agents Chemother"},{"key":"87_CR13","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1194\/jlr.R073452","volume":"58","author":"AN Bukiya","year":"2017","unstructured":"Bukiya AN, Dopico AM (2017) Cholesterol and soluble proteins. J Lipid Res 58:1044\u20131054","journal-title":"J Lipid Res"},{"key":"87_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1675-x","volume":"16","author":"JN Burrows","year":"2017","unstructured":"Burrows JN, Duparc S, Gutteridge WE, Hooft van Huijsduijnen R, Kaszubska W, Macintyre F, Mazzuri S, M\u00f6hrle JJ, Wells TNC (2017) New developments in anti-malarial target candidate and product profiles. Malar J 16:26","journal-title":"Malar J"},{"key":"87_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11239-0","volume":"10","author":"G Camarda","year":"2019","unstructured":"Camarda G, Jirawatcharadech P, Priestley RS, Saif A, March S, Wong MHL, Leung S, Miller AB, Baker DA, Alano P et al (2019) Antimalarial activity of primaquine operates via a two-step biochemical relay. Nat Commun 10:3226","journal-title":"Nat Commun"},{"key":"87_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0714-3","volume":"14","author":"I Chen","year":"2015","unstructured":"Chen I, Poirot E, Newman M, Kandula D, Shah R, Hwang J, Cohen JM, Gosling R, Rooney L (2015) An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa. Malar J 14:204","journal-title":"Malar J"},{"key":"87_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S1995-7645(11)60232-0","volume":"4","author":"UM Chukwuocha","year":"2011","unstructured":"Chukwuocha UM, Eke KN (2011) Malaria parasite status and cholesterol level of malaria patients in parts of the IMO River Basin of Nigeria. Asian Pac J Trop Med 4:993\u2013996","journal-title":"Asian Pac J Trop Med"},{"key":"87_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrmicro3139","volume":"11","author":"I Coppens","year":"2013","unstructured":"Coppens I (2013) Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat Rev Microbiol 11:823\u2013835","journal-title":"Nat Rev Microbiol"},{"key":"87_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev.micro.54.1.129","volume":"54","author":"I Coppens","year":"2000","unstructured":"Coppens I, Courtoy PJ (2000) The adaptative mechanisms of Trypanosoma brucei for sterol homeostasis in its different life-cycle environments. Annu Rev Microbiol 54:129\u2013156","journal-title":"Annu Rev Microbiol"},{"key":"87_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2006.01.056","volume":"125","author":"I Coppens","year":"2006","unstructured":"Coppens I, Dunn JD, Romano JD, Pypaert M, Zhang H, Boothroyd JC, Joiner KA (2006) Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell 125:261\u2013274","journal-title":"Cell"},{"key":"87_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1083\/jcb.149.1.167","volume":"149","author":"I Coppens","year":"2000","unstructured":"Coppens I, Sinai AP, Joiner KA (2000) Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J Cell Biol 149:167\u2013180","journal-title":"J Cell Biol"},{"key":"87_CR22","doi-asserted-by":"publisher","first-page":"e1002178","DOI":"10.1371\/journal.ppat.1002178","volume":"7","author":"ER Derbyshire","year":"2011","unstructured":"Derbyshire ER, Mota MM, Clardy J (2011) The next opportunity in anti-malaria drug discovery: the liver stage. PLoS Pathog 7:e1002178","journal-title":"PLoS Pathog"},{"key":"87_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ et al (2009) Artemisinin resistance in Plasmodium falciparum malaria. N. Engl J Med 361:455\u2013467","journal-title":"N. Engl J Med"},{"key":"87_CR24","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/cmi.12107","volume":"15","author":"K Ehrenman","year":"2013","unstructured":"Ehrenman K, Wanyiri JW, Bhat N, Ward HD, Coppens I (2013) Cryptosporidium parvum scavenges LDL-derived cholesterol and micellar cholesterol internalized into enterocytes. Cell Microbiol 15:1182\u20131197","journal-title":"Cell Microbiol"},{"key":"87_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2658-5","volume":"18","author":"PS Fasinu","year":"2019","unstructured":"Fasinu PS, Nanayakkara NPD, Wang YH, Chaurasiya ND, Herath HMB, McChesney JD, Avula B, Khan I, Tekwani BL, Walker LA (2019) Formation primaquine-5,6-orthoquinone, the putative active and toxic metabolite of primaquine via direct oxidation in human erythrocytes. Malar J 18:30","journal-title":"Malar J"},{"key":"87_CR26","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","volume":"7","author":"B Forte","year":"2021","unstructured":"Forte B, Ottilie S, Plater A, Campo B, Dechering KJ, Gamo FJ, Goldberg DE, Istvan ES, Lee M, Lukens AK et al (2021) Prioritization of molecular targets for antimalarial drug discovery. ACS Infect Dis 7:2764\u20132776","journal-title":"ACS Infect Dis"},{"key":"87_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1128\/EC.5.5.849-860.2006","volume":"5","author":"S Frankland","year":"2006","unstructured":"Frankland S, Adisa A, Horrocks P, Taraschi TF, Schneider T, Elliott SR, Rogerson SJ, Knuepfer E, Cowman AF, Newbold CI et al (2006) Delivery of the malaria virulence protein PfEMP1 to the erythrocyte surface requires cholesterol-rich domains. Eukaryot Cell 5:849\u2013860","journal-title":"Eukaryot Cell"},{"key":"87_CR28","doi-asserted-by":"publisher","first-page":"e1009259","DOI":"10.1371\/journal.ppat.1009259","volume":"17","author":"M Fraser","year":"2021","unstructured":"Fraser M, Jing W, Br\u00f6er S, Kurth F, Sander LE, Matuschewski K, Maier AG (2021) Breakdown in membrane asymmetry regulation leads to monocyte recognition of P. falciparum-infected red blood cells. PLoS Pathog 17:e1009259","journal-title":"PLoS Pathog"},{"key":"87_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"FJ Gamo","year":"2010","unstructured":"Gamo FJ, Sanz LM, Vidal J, De Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DVS, Kumar V, Hasan S et al (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465:305\u2013310","journal-title":"Nature"},{"key":"87_CR30","first-page":"CD008152","volume":"2014","author":"PM Graves","year":"2014","unstructured":"Graves PM, Gelband H, Garner P (2014) Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Cochrane Database Syst Rev 2014:CD008152","journal-title":"Cochrane Database Syst Rev"},{"key":"87_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","volume":"465","author":"WA Guiguemde","year":"2010","unstructured":"Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F et al (2010) Chemical genetics of Plasmodium falciparum. Nature 465:311\u2013315","journal-title":"Nature"},{"key":"87_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","volume":"16","author":"K Haldar","year":"2018","unstructured":"Haldar K, Bhattacharjee S, Safeukui I (2018) Drug resistance in Plasmodium. Nat Rev Microbiol 16:156\u2013170","journal-title":"Nat Rev Microbiol"},{"key":"87_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1462-5822.2002.00204.x","volume":"4","author":"K Haldar","year":"2002","unstructured":"Haldar K, Mohandas N, Samuel BU, Harrison T, Hiller NL, Akompong T, Cheresh P (2002) Protein and lipid trafficking induced in erythrocytes infected by malaria parasites. Cell Microbiol 4:383\u2013395","journal-title":"Cell Microbiol"},{"key":"87_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59552-9","volume":"10","author":"EH Hayakawa","year":"2020","unstructured":"Hayakawa EH, Yamaguchi K, Mori M, Nardone G (2020) Real-time cholesterol sorting in Plasmodium falciparum-erythrocytes as revealed by 3D label-free imaging. Sci Rep 10:2794","journal-title":"Sci Rep"},{"issue":"2","key":"87_CR35","doi-asserted-by":"publisher","first-page":"e1011987","DOI":"10.1371\/journal.ppat.1011987","volume":"20","author":"JA Hayward","year":"2023","unstructured":"Hayward JA, Makota FV, Cihalova D, Rajendran E, Zwahlen SM, Shuttleworth L, Wiedemann U, Spry C, Saliba KJ, Maier AG et al (2023) A screen of drug-like molecules identifies chemically diverse electron transport chain inhibitors in apicomplexan parasites. PLoS Pathog 20(2):e1011987","journal-title":"PLoS Pathog"},{"key":"87_CR36","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1128\/AAC.38.6.1392","volume":"38","author":"E Holfels","year":"1994","unstructured":"Holfels E, McAuley J, Mack D, Milhous WK, McLeod R (1994) In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii. Antimicrob Agents Chemother 38:1392\u20131396","journal-title":"Antimicrob Agents Chemother"},{"key":"87_CR37","doi-asserted-by":"publisher","first-page":"e40529","DOI":"10.7554\/eLife.40529","volume":"8","author":"ES Istvan","year":"2019","unstructured":"Istvan ES, Das S, Bhatnagar S, Beck JR, Owen E, Llinas M, Ganesan SM, Niles JC, Winzeler E, Vaidya AB et al (2019) Plasmodium Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasis. eLife 8:e40529","journal-title":"eLife"},{"key":"87_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.molbiopara.2005.09.007","volume":"145","author":"CJ Janse","year":"2006","unstructured":"Janse CJ, Franke-Fayard B, Mair GR, Ramesar J, Thiel C, Engelmann S, Matuschewski K, Gemert GJ, Van, Sauerwein RW, Waters AP (2006) High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol Biochem Parasitol 145:60\u201370","journal-title":"Mol Biochem Parasitol"},{"key":"87_CR39","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1128\/AAC.00225-07","volume":"51","author":"M Kaiser","year":"2007","unstructured":"Kaiser M, Wittlin S, Nehrbass-Stuedli A, Dong Y, Wang X, Hemphill A, Matile H, Brun R, Vennerstrom JL (2007) Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160). Antimicrob Agents Chemother 51:2991\u20132993","journal-title":"Antimicrob Agents Chemother"},{"key":"87_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.molbiopara.2012.06.001","volume":"185","author":"TWA Kooij","year":"2012","unstructured":"Kooij TWA, Rauch MM, Matuschewski K (2012) Expansion of experimental genetics approaches for Plasmodium berghei with versatile transfection vectors. Mol Biochem Parasitol 185:19\u201326","journal-title":"Mol Biochem Parasitol"},{"key":"87_CR41","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.cell.2009.03.049","volume":"137","author":"HJ Kwon","year":"2009","unstructured":"Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137:1213\u20131224","journal-title":"Cell"},{"key":"87_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1462-5822.2010.01555.x","volume":"13","author":"M Labaied","year":"2011","unstructured":"Labaied M, Jayabalasingham B, Bano N, Cha SJ, Sandoval J, Guan G, Coppens I (2011) Plasmodium salvages cholesterol internalized by LDL and synthesized de novo in the liver. Cell Microbiol 13:569\u2013586","journal-title":"Cell Microbiol"},{"key":"87_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1710775","volume":"380","author":"MVG Lacerda","year":"2019","unstructured":"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, Yilma D, Batista Pereira D, Espino FEJ, Mia RZ et al (2019) Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N. Engl J Med 380:215\u2013228","journal-title":"N. Engl J Med"},{"key":"87_CR44","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S0140-6736(78)90998-4","volume":"311","author":"AJ Lambrecht","year":"1978","unstructured":"Lambrecht AJ, Snoeck J, Timmermans U (1978) Transient an-alpha- lipoproteinaemia in man during infection by Plasmodium vivax. Lancet 311:1206","journal-title":"Lancet"},{"key":"87_CR45","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1093\/emboj\/19.14.3556","volume":"19","author":"S Lauer","year":"2000","unstructured":"Lauer S, VanWye J, Harrison T, McManus H, Samuel BU, Hiller NL, Mohandas N, Haldar K (2000) Vacuolar uptake of host components, and a role for cholesterol and sphingomyelin in malarial infection. EMBO J 19:3556\u20133564","journal-title":"EMBO J"},{"key":"87_CR46","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(00)02352-7","volume":"355","author":"B Lell","year":"2000","unstructured":"Lell B, Faucher JF, Missinou MA, Borrmann S, Dangelmaier O, Horton J, Kremsner PG (2000) Malaria chemoprophylaxis with tafenoquine: a randomised study. Lancet 355:2041\u20132045","journal-title":"Lancet"},{"key":"87_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.pt.2018.11.010","volume":"35","author":"AG Maier","year":"2019","unstructured":"Maier AG, Matuschewski K, Zhang M, Rug M (2019) Plasmodium falciparum. Trends Parasitol 35:481\u2013482","journal-title":"Trends Parasitol"},{"key":"87_CR48","doi-asserted-by":"publisher","first-page":"984049","DOI":"10.3389\/fcimb.2022.984049","volume":"12","author":"AG Maier","year":"2022","unstructured":"Maier AG, van Ooij C (2022) The role of cholesterol in invasion and growth of malaria parasites. Front Cell Infect Microbiol 12:984049","journal-title":"Front Cell Infect Microbiol"},{"key":"87_CR49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s11745-008-3194-1","volume":"43","author":"AL McIntosh","year":"2008","unstructured":"McIntosh AL, Atshaves BP, Huang H, Gallegos AM, Kier AB, Schroeder F (2008) Fluorescence techniques using dehydroergosterol to study cholesterol trafficking. Lipids 43:1185\u20131208","journal-title":"Lipids"},{"key":"87_CR50","first-page":"11","volume":"13","author":"F Megabiaw","year":"2022","unstructured":"Megabiaw F, Eshetu T, Kassahun Z, Aemero M (2022) Liver enzymes and lipid profile of malaria patients before and after antimalarial drug treatment at Dembia Primary Hospital and Teda Health Center, Northwest, Ethiopia. Res Rep. Trop Med 13:11\u201323","journal-title":"Res Rep. Trop Med"},{"key":"87_CR51","first-page":"407","volume":"47","author":"MD Miner","year":"2009","unstructured":"Miner MD, Chang JC, Pandey AK, Sassetti CM, Sherman DR (2009) Role of cholesterol in Mycobacterium tuberculosis infection. Indian J Exp Biol 47:407\u2013411","journal-title":"Indian J Exp Biol"},{"key":"87_CR52","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s12639-015-0718-5","volume":"40","author":"M Mondal","year":"2016","unstructured":"Mondal M, Kundu JK, Misra KK (2016) Variation in lipid and fatty acid uptake among nematode and cestode parasites and their host, domestic fowl: host\u2013parasite interaction. J Parasit Dis 40:1494\u20131518","journal-title":"J Parasit Dis"},{"key":"87_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/cmdc.201700579","volume":"13","author":"M Morake","year":"2018","unstructured":"Morake M, Coertzen D, Ngwane A, Wentzel JF, Wong HN, Smit FJ, Birkholtz LM, Pietersen RD, Baker B, Wiid I et al (2018) Preliminary evaluation of artemisinin\u2013cholesterol conjugates as potential drugs for the treatment of intractable forms of malaria and tuberculosis. ChemMedChem 13:67\u201377","journal-title":"ChemMedChem"},{"key":"87_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-263","volume":"10","author":"CA Morris","year":"2011","unstructured":"Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin CS, Fleckenstein L (2011) Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J 10:263","journal-title":"Malar J"},{"key":"87_CR55","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1084\/jem.20110039","volume":"208","author":"SC Nair","year":"2011","unstructured":"Nair SC, Brooks CF, Goodman CD, Strurm A, McFadden GI, Sundriyal S, Anglin JL, Song Y, Moreno SNJ, Striepen B (2011) Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. J Exp Med 208:1547\u20131559","journal-title":"J Exp Med"},{"key":"87_CR56","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM (2008) Evidence of artemisinin-resistant malaria in Western Cambodia. N. Engl J Med 359:2619\u20132620","journal-title":"N. Engl J Med"},{"key":"87_CR57","doi-asserted-by":"publisher","first-page":"e61675","DOI":"10.7554\/eLife.61675","volume":"9","author":"AJ O\u2019Neal","year":"2020","unstructured":"O\u2019Neal AJ, Butler LR, Rolandelli A, Gilk SD, Pedra JHF (2020) Lipid hijacking: a unifying theme in vector-borne diseases. eLife 9:e61675","journal-title":"eLife"},{"key":"87_CR58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1159\/000430812","volume":"24","author":"AE Orimadegun","year":"2015","unstructured":"Orimadegun AE, Orimadegun BE (2015) Serum apolipoprotein-A1 and cholesterol levels in Nigerian children with Plasmodium falciparum infection. Med Princ Pract 24:318\u2013324","journal-title":"Med Princ Pract"},{"key":"87_CR59","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1091\/mbc.e16-07-0531","volume":"28","author":"W Petersen","year":"2017","unstructured":"Petersen W, Stenzel W, Silvie O, Blanz J, Saftig P, Matuschewski K, Ingmundson A (2017) Sequestration of cholesterol within the host late endocytic pathway restricts liver-stage Plasmodium development. Mol Biol Cell 28:726","journal-title":"Mol Biol Cell"},{"key":"87_CR60","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1021\/acsinfecdis.8b00113","volume":"4","author":"JB Radke","year":"2018","unstructured":"Radke JB, Burrows JN, Goldberg DE, Sibley LD (2018) Evaluation of current and emerging anti-malarial medicines for inhibition of Toxoplasma gondii growth in vitro. ACS Infect Dis 4:1264","journal-title":"ACS Infect Dis"},{"key":"87_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14455","volume":"8","author":"E Rajendran","year":"2017","unstructured":"Rajendran E, Hapuarachchi SV, Miller CM, Fairweather SJ, Cai Y, Smith NC, Cockburn IA, Bro\u00ebr S, Kirk K, van Dooren GG (2017) Cationic amino acid transporters play key roles in the survival and transmission of apicomplexan parasites. Nat Commun 8:1\u20134455","journal-title":"Nat Commun"},{"key":"87_CR62","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jacl.2018.02.019","volume":"12","author":"A Rakovac Tisdall","year":"2018","unstructured":"Rakovac Tisdall A, Crowley VEF, Crook MA (2018) Undetectable high-density lipoprotein cholesterol in acute malaria. J Clin Lipido 12:822\u2013825","journal-title":"J Clin Lipido"},{"key":"87_CR63","doi-asserted-by":"publisher","first-page":"jcs259592","DOI":"10.1242\/jcs.259592","volume":"135","author":"MC Ridgway","year":"2022","unstructured":"Ridgway MC, Cihalova D, Brown SHJ, Tran P, Mitchell TW, Maier AG (2022) Analysis of sex-specific lipid metabolism of Plasmodium falciparum points to the importance of sphingomyelin for gametocytogenesis. J Cell Sci 135:jcs259592","journal-title":"J Cell Sci"},{"key":"87_CR64","doi-asserted-by":"publisher","first-page":"e00671","DOI":"10.1128\/msphere.00671-20","volume":"5","author":"MC Ridgway","year":"2020","unstructured":"Ridgway MC, Shea KS, Cihalova D, Maier AG (2020) Novel method for the separation of male and female gametocytes of the malaria parasite Plasmodium falciparum that enables biological and drug discovery. mSphere 5:e00671\u201320","journal-title":"mSphere"},{"key":"87_CR65","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/milmed\/134.9.802","volume":"134","author":"KH Rieckmann","year":"1969","unstructured":"Rieckmann KH, McNamara JV, Kass L, Powell RD (1969) Gametocytocidal and sporontocidal effects of primaquine upon two strains of Plasmodium falciparum. Mil Med 134:802\u2013819","journal-title":"Mil Med"},{"key":"87_CR66","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann M, McNamara C, Yeung BKS, Lee MCS, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J et al (2010) Spiroindolones, a potent compound class for the treatment of malaria. Science 329:1175\u20131180","journal-title":"Science"},{"key":"87_CR67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B et al (2012) Fiji - an open source platform for biological image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"87_CR68","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M (2004) Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48:1803\u20131806","journal-title":"Antimicrob Agents Chemother"},{"key":"87_CR69","doi-asserted-by":"publisher","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","volume":"8","author":"T Spangenberg","year":"2013","unstructured":"Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TNC, Willis P (2013) The open access Malaria Box: a drug discovery catalyst for neglected diseases. PLoS ONE 8:e62906","journal-title":"PLoS ONE"},{"key":"87_CR70","doi-asserted-by":"publisher","first-page":"e54974","DOI":"10.1371\/journal.pone.0054974","volume":"8","author":"C Spry","year":"2013","unstructured":"Spry C, Macuamule C, Lin Z, Virga KG, Lee RE, Strauss E, Saliba KJ (2013) Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated. PLoS ONE 8:e54974","journal-title":"PLoS ONE"},{"key":"87_CR71","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gn\u00e4dig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S et al (2015) K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science 347:428\u2013431","journal-title":"Science"},{"key":"87_CR72","doi-asserted-by":"publisher","first-page":"e00534","DOI":"10.1128\/mSphere.00534-17","volume":"3","author":"G Subramanian","year":"2018","unstructured":"Subramanian G, Belekar MA, Shukla A, Tong JX, Sinha A, Chu TTT, Kulkarni AS, Preiser PR, Reddy DS, Tan KSW et al (2018) Targeted phenotypic screening in Plasmodium falciparum and Toxoplasma gondii reveals novel modes of action of Medicines for Malaria Venture Malaria Box molecules. mSphere 3:e00534\u201317","journal-title":"mSphere"},{"key":"87_CR73","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1242\/bio.20147732","volume":"3","author":"F Tokumasu","year":"2014","unstructured":"Tokumasu F, Crivat G, Ackerman H, Hwang J, Wellems TE (2014) Inward cholesterol gradient of the membrane system in P. falciparum-infected erythrocytes involves a dilution effect from parasite-produced lipids. Biol Open 3:529\u2013541","journal-title":"Biol Open"},{"key":"87_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1130-z","volume":"15","author":"PN Tran","year":"2016","unstructured":"Tran PN, Brown SHJ, Rug M, Ridgway MC, Mitchell TW, Maier AG (2016) Changes in lipid composition during sexual development of the malaria parasite Plasmodium falciparum. Malar J 15:73","journal-title":"Malar J"},{"key":"87_CR75","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","volume":"44","author":"N Vale","year":"2009","unstructured":"Vale N, Moreira R, Gomes P (2009) Primaquine revisited six decades after its discovery. Eur J Med Chem 44:937\u2013953","journal-title":"Eur J Med Chem"},{"key":"87_CR76","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nature02779","volume":"430","author":"JL Vennerstrom","year":"2004","unstructured":"Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FCK, Chollet J, Dong Y, Dorn A, Hunziker D, Matile H et al (2004) Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430:900\u2013904","journal-title":"Nature"},{"key":"87_CR77","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.4269\/ajtmh.16-0721","volume":"96","author":"BJ Visser","year":"2017","unstructured":"Visser BJ, De Vries SG, Vingerling R, Gritter M, Kroon D, Aguilar LC, Kraan RBJ, Wieten RW, Danion F, Sjouke B et al (2017) Serum lipids and lipoproteins during uncomplicated malaria: a cohort study in Lambar\u00e9n\u00e9, Gabon. Am J Trop Med Hyg 96:1205\u20131214","journal-title":"Am J Trop Med Hyg"},{"key":"87_CR78","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1124\/dmd.120.000316","volume":"49","author":"P Wang","year":"2021","unstructured":"Wang P, Chen S, Wang Y, Wang X, Yan L, Yang K, Zhong XB, Han S, Zhang L (2021) The long noncoding RNA hepatocyte nuclear factor 4a antisense RNA 1 negatively regulates cytochrome P450 enzymes in Huh7 cells via histone modifications. Drug Metab Dispos 49:361\u2013368","journal-title":"Drug Metab Dispos"},{"key":"87_CR79","unstructured":"WHO (2023) World Malaria Report 2023. World Health Organization, Geneva, Switzerland"},{"key":"87_CR80","unstructured":"WHO UCN\/GMP (2023) WHO guidelines for malaria, 16 October 2023. World Health Organization, Geneva, Switzerland"},{"key":"87_CR81","unstructured":"Witkowski B, Menard D, Amaratunga C, Fairhurst R (2013) Ring-stage survival assays (RSA) to evaluate the in-vitro and ex-vivo susceptibility of Plasmodium falciparum to artemisinins. RSAv1 procedure. Institute Pasteur du Cambodge \u2013 National Institutes of Health, Cambodia"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00087-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00087-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00087-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:03:19Z","timestamp":1785866599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00087-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":81,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,15]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00087-1","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MF, BC, PAY, MM and AGM are named inventors on a patent application (PCT\/AU2023\/050041) by the Australian National University that covers the technology described.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"4"}}